...
search icon
mxct-img

MaxCyte Inc, Common Stock

MXCT

NSQ

$4.17

+$0.1

(2.46%)

1D
Industry: Health Care Equipment & Supplies Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$439.86M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
529.24K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.16
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$3.17 L
$5.26 H
$4.17

About MaxCyte Inc, Common Stock

MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes next-generation cell therapies in the United States and internationally. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. It licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland. more

Industry: Health Care Equipment & SuppliesSector: Health Care

Returns

Time FrameMXCTSectorS&P500
1-Week Return-5.01%-0.03%1.53%
1-Month Return-10.13%4.56%4.75%
3-Month Return21.22%1.29%2.77%
6-Month Return5.57%-3.54%12.18%
1-Year Return-10.71%1.59%22.34%
3-Year Return-36.24%13.55%38.91%
5-Year Return-75.47%40.85%80.7%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue21.62M26.17M33.89M44.26M41.29M[{"date":"2019-12-31","value":48.85,"profit":true},{"date":"2020-12-31","value":59.12,"profit":true},{"date":"2021-12-31","value":76.58,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":93.28,"profit":true}]
Cost of Revenue2.50M2.77M3.65M5.10M4.74M[{"date":"2019-12-31","value":49.02,"profit":true},{"date":"2020-12-31","value":54.27,"profit":true},{"date":"2021-12-31","value":71.54,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":93.01,"profit":true}]
Gross Profit19.12M23.40M30.25M39.16M36.55M[{"date":"2019-12-31","value":48.83,"profit":true},{"date":"2020-12-31","value":59.75,"profit":true},{"date":"2021-12-31","value":77.23,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":93.32,"profit":true}]
Gross Margin88.44%89.43%89.24%88.48%88.51%[{"date":"2019-12-31","value":98.9,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":99.79,"profit":true},{"date":"2022-12-31","value":98.94,"profit":true},{"date":"2023-12-31","value":98.98,"profit":true}]
Operating Expenses31.54M34.46M48.44M66.52M84.84M[{"date":"2019-12-31","value":37.18,"profit":true},{"date":"2020-12-31","value":40.61,"profit":true},{"date":"2021-12-31","value":57.09,"profit":true},{"date":"2022-12-31","value":78.41,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(12.42M)(11.06M)(18.19M)(27.36M)(48.30M)[{"date":"2019-12-31","value":-1242000000,"profit":false},{"date":"2020-12-31","value":-1105670000,"profit":false},{"date":"2021-12-31","value":-1818860000,"profit":false},{"date":"2022-12-31","value":-2736050000,"profit":false},{"date":"2023-12-31","value":-4829900000,"profit":false}]
Total Non-Operating Income/Expense(950.00K)(1.52M)(1.79M)7.58M19.76M[{"date":"2019-12-31","value":-4.81,"profit":false},{"date":"2020-12-31","value":-7.69,"profit":false},{"date":"2021-12-31","value":-9.05,"profit":false},{"date":"2022-12-31","value":38.36,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(12.89M)(11.82M)(19.08M)(23.57M)(37.92M)[{"date":"2019-12-31","value":-1289500000,"profit":false},{"date":"2020-12-31","value":-1181640000,"profit":false},{"date":"2021-12-31","value":-1908220000,"profit":false},{"date":"2022-12-31","value":-2357080000,"profit":false},{"date":"2023-12-31","value":-3792300000,"profit":false}]
Income Taxes681.10K825.60K1.04M(3.79M)4.00M[{"date":"2019-12-31","value":17.01,"profit":true},{"date":"2020-12-31","value":20.62,"profit":true},{"date":"2021-12-31","value":26.09,"profit":true},{"date":"2022-12-31","value":-94.67,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income After Taxes(13.58M)(12.64M)(20.13M)(19.78M)(41.93M)[{"date":"2019-12-31","value":-1357610000,"profit":false},{"date":"2020-12-31","value":-1264200000,"profit":false},{"date":"2021-12-31","value":-2012660000,"profit":false},{"date":"2022-12-31","value":-1978110000,"profit":false},{"date":"2023-12-31","value":-4192610500,"profit":false}]
Income From Continuous Operations(12.89M)(11.82M)(19.08M)(23.57M)(37.45M)[{"date":"2019-12-31","value":-1289500000,"profit":false},{"date":"2020-12-31","value":-1181640000,"profit":false},{"date":"2021-12-31","value":-1908220000,"profit":false},{"date":"2022-12-31","value":-2357080000,"profit":false},{"date":"2023-12-31","value":-3745460000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(13.58M)(12.64M)(20.13M)(19.78M)(37.92M)[{"date":"2019-12-31","value":-1357610000,"profit":false},{"date":"2020-12-31","value":-1264200000,"profit":false},{"date":"2021-12-31","value":-2012660000,"profit":false},{"date":"2022-12-31","value":-1978110000,"profit":false},{"date":"2023-12-31","value":-3792300000,"profit":false}]
EPS (Diluted)(0.20)(0.16)(0.20)(0.23)(0.37)[{"date":"2019-12-31","value":-19.84,"profit":false},{"date":"2020-12-31","value":-16.21,"profit":false},{"date":"2021-12-31","value":-20,"profit":false},{"date":"2022-12-31","value":-23,"profit":false},{"date":"2023-12-31","value":-37,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

MXCT
Cash Ratio 8.73
Current Ratio 9.81
Quick Ratio 9.22

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

MXCT
ROA (LTM) -11.25%
ROE (LTM) -16.00%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

MXCT
Debt Ratio Lower is generally better. Negative is bad. 0.14
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.86

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

MXCT
Trailing PE NM
Forward PE NM
P/S (TTM) 9.65
P/B 2.06
Price/FCF NM
EV/R 6.56
EV/Ebitda NM

FAQs

What is MaxCyte Inc share price today?

MaxCyte Inc (MXCT) share price today is $4.17

Can Indians buy MaxCyte Inc shares?

Yes, Indians can buy shares of MaxCyte Inc (MXCT) on Vested. To buy MaxCyte Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in MXCT stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of MaxCyte Inc be purchased?

Yes, you can purchase fractional shares of MaxCyte Inc (MXCT) via the Vested app. You can start investing in MaxCyte Inc (MXCT) with a minimum investment of $1.

How to invest in MaxCyte Inc shares from India?

You can invest in shares of MaxCyte Inc (MXCT) via Vested in three simple steps:

  • Click on Sign Up or Invest in MXCT stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in MaxCyte Inc shares
What is MaxCyte Inc 52-week high and low stock price?

The 52-week high price of MaxCyte Inc (MXCT) is $5.26. The 52-week low price of MaxCyte Inc (MXCT) is $3.17.

What is MaxCyte Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of MaxCyte Inc (MXCT) is 2.06

What is the Market Cap of MaxCyte Inc?

The market capitalization of MaxCyte Inc (MXCT) is $439.86M

What is MaxCyte Inc’s stock symbol?

The stock symbol (or ticker) of MaxCyte Inc is MXCT

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top